Table of contents

  • Preliminary material
    • Title and verso page
    • Contents
    • Acknowledgments
    • Abbreviations
    • Summary
  • Body section
    • 1 Introduction
      • Rationale for this report
      • Classes of medications
      • Management guidelines for asthma
      • Management guidelines for COPD
      • Context of this report
      • Questions considered in this report
    • 2 Data and methods
      • Data sources
      • Methods of data analyses
    • 3 Use of medications for obstructive airway disease
      • Overall medication use
      • Use of SABA for asthma (NSW Health Survey)
      • Corticosteroids
      • Long-acting bronchodilators (LABA and LAMA) prescribed without ICS
      • Anti-immunoglobulin E therapy (omalizumab)
      • Leukotriene receptor antagonists
      • Use of asthma medication in children (LSAC data)
    • 4 Discussion and implications
  • End matter
    • Appendix 1: PBS items included in the analyses for this report
    • Appendix 2: PBS data processing
    • Appendix 3: Inhaled corticosteroid potency classification
    • Glossary
    • References
    • List of tables
    • List of figures
    • Related publications